Pittsburgh, PA – According to filings with the U.S. Securities and Exchange Commission, Alung Technologies is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President, Vince Testa played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Alung Technologies

ALung Technologies has developed the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis,a simple, less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patient’s lungs to rest and heal.

To learn more about Alung Technologies, visit http://www.alung.com/

Contact:
Vince Testa, President
412-697-3370
vtesta@alung.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved